eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

  Tools   Community
All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms       Ask question       Write review       Answered/ Unanswered       Reviews       WellConnected

From FDA reports: drug interactions between Jakafi, Lisinopril, Allopurinol, Lasix, Doxazosin Mesylate, Ciprofloxacin for a Male patient aged 71

This is a personalized study for a 71 year old male patient. The study is created by eHealthMe based on reports of 8 people who take the same drugs and have drug interactionsfrom FDA.

On Dec, 6, 2014: 8 people who reported to have interactions when taking Jakafi, Lisinopril, Allopurinol, Lasix, Doxazosin Mesylate, Ciprofloxacin are studied

Trend of Jakafi, Lisinopril, Allopurinol, Lasix, Doxazosin Mesylate, Ciprofloxacin's drug interactions, side effects, and effectiveness reports (8475442)

Information of the patient in this study:

Age: 71

Gender: male

Conditions: Myelofibrosis

Drugs taking:
- Jakafi
- Lisinopril
- Allopurinol
- Lasix
- Jakafi
- Doxazosin Mesylate
- Ciprofloxacin
- Jakafi: used for < 1 month

Drug interactions have: Nephrolithiasis

eHealthMe real world results:

Comparison with this patient's adverse outcomes among males aged 71 (±5):

InteractionNumber of reports
Nephrolithiasis (calculi in the kidneys)1 (100.00%)

Most common interactions experienced by males aged 71 (±5) in the use of Jakafi, Lisinopril, Allopurinol, Lasix, Doxazosin Mesylate, Ciprofloxacin:

InteractionNumber of reports
Nephrolithiasis (calculi in the kidneys)1

Most common interactions experienced by males aged 71 (±5) in long term use of Jakafi, Lisinopril, Allopurinol, Lasix, Doxazosin Mesylate, Ciprofloxacin:

None.

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

InteractionNumber of reports
Nephrolithiasis (calculi in the kidneys)4 (50.00%)

Most common interactions experienced by people in the use of Jakafi, Lisinopril, Allopurinol, Lasix, Doxazosin Mesylate, Ciprofloxacin:

InteractionNumber of reports
Pain8
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)8
Atrial Fibrillation (fibrillation of the muscles of the atria of the heart)8
Anhedonia (inability to experience pleasure from activities usually found enjoyable)8
Death8
Lung Infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)8
Injury8
Arteriosclerosis (thickening and hardening of arteries)8
Pleural Effusion (water on the lungs)8
Arteriovenous Fistula8

Most common interactions experienced by people in long term use of Jakafi, Lisinopril, Allopurinol, Lasix, Doxazosin Mesylate, Ciprofloxacin:

None.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.